Continuous-Flow Isoniazid Synthesis Without Intermediate Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing synthesis methodologies for Isoniazid production rely on batch reactor processes that use significant volumes of organic solvents and isolate intermediates, leading to high costs and inefficiencies, with no existing methods utilizing flow chemistry.

Innovation Solution

A multistep continuous flow synthesis method using microreactor technology, involving the hydrolysis of 4-cyano pyridine to isonicotinamide and subsequent reaction with hydrazine hydrate, optimized for yield and efficiency with specific molar ratios, temperatures, and residence times.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If batch reactor processes are used for Isoniazid synthesis, then the process is simple to operate, but significant volumes of organic solvents are used and intermediates must be isolated, leading to high costs and inefficiencies

Engineering Contradiction:
Improveease of operationVSAvoidsolvent usage
Core Design Contradiction:
Ease of operationVSLoss of substance

Solution Approach 1:

The patent implements continuous flow chemistry where reactions proceed continuously through a series of flow reactors rather than batch processing. This allows the intermediate to react continuously with hydrazine hydrate without isolation, eliminating the need for solvent-intensive workup and isolation steps while maintaining operational simplicity through automated flow control

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent combines multiple reaction steps (hydrolysis of nitrile to amide, then amide to hydrazide formation) into a single continuous flow process where the intermediate from step a) directly feeds into step b). This merging eliminates the isolation step between reactions and reduces overall solvent requirements while maintaining ease of operation through integrated flow reactor design

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If batch reactor processes are used for Isoniazid synthesis, then the process is well-established, but the isolation of intermediates at each step increases solvent usage and process inefficiency

Engineering Contradiction:
ImprovereliabilityVSAvoidprocess efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The continuous flow process maintains reliable reaction conditions through precise control of residence time, temperature, and reagent ratios in each flow reactor stage. The intermediate flows continuously from the first reactor to the second without isolation, eliminating time losses and solvent usage associated with batch isolation steps while maintaining product quality and process reliability

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent uses the flow reactor system itself as an intermediary that transports and reacts the intermediate species without requiring physical isolation. The intermediate generated in step a) is carried by the flow medium directly into step b), acting as a continuous intermediary that eliminates the need for separate isolation and purification steps, thereby improving productivity while maintaining reliability

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of substance

If flow chemistry methodology is used for Isoniazid production, then solvent usage is reduced and efficiency is improved, but no existing process demonstrates this approach

Engineering Contradiction:
Improvesolvent usageVSAvoidease of manufacture
Core Design Contradiction:
Loss of substanceVSEase of manufacture

Solution Approach 1:

The patent segments the synthesis process into distinct flow reactor modules, each optimized for a specific reaction step (nitrile hydrolysis in the first reactor, hydrazide formation in the second). This segmentation allows each module to be independently optimized and controlled, reducing solvent usage in each step while maintaining ease of manufacture through modular design that can be implemented using commercially available flow reactor systems

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves a yield of over 90% Isoniazid production with reduced solvent use and improved safety, addressing the inefficiencies of traditional batch processes.

Implementation Method 1

reacting 4-cyano pyridine of Formula 12 with NaOH in a molar ratio of 4-cyano pyridine:NaOH of about 1:0.1 to about 1:0.7 at a temperature of about 90° C. to about 105° C. to produce the intermediate isonicotinamide of Formula 13

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

reacting the intermediate isonicotinamide of Formula 13 with hydrazine hydrate in a molar ratio of 4-cyano pyridine:hydrazine hydrate of about 1:1.75 to about 1:2.50 at a temperature of about 100° C. to about 120° C.

Methodology Applied
Scientific EffectChemical reaction: Reaction (physics)

Data Source

PatentUS12459897B2Continuous flow synthesis method for the manufacture of isoniazid
Publication Date: 2025.11.04 NELSON MANDELA METROPOLITAN UNIV
  • US12459897B2 patent drawing
  • US12459897B2 patent drawing
  • US12459897B2 patent drawing

AI summary

A multistep continuous flow synthesis method for the manufacture of isonicotinyl-hydrazide (Isoniazid) comprising reacting 4-cyano pyridine with NaOH at a specified molar ratio and temperature range to produce the intermediate isonicotinamide, which intermediate is reacted with hydrazine hydrate, without isolation thereof, at a specified molar ratio and temperature range to produce isonicotinyl-hydrazide (Isoniazid) in a yield greater than about 90%.